| Literature DB >> 30795860 |
Dhanapal Govindaraj1, Swati Sharma1, Naresh Singh2, Naveen Arora3.
Abstract
Peptide immunotherapy (PIT) represents a safe and efficacious therapeutic modality for allergic diseases. Present study evaluates immunotherapeutic potential of T cell peptides of major cockroach allergen, Per a 10 in murine model of airway allergy. Treatment with peptides T-P8 and T-P10 demonstrated maximal resolution of pathophysiological features such as reduced recruitment of inflammatory cells to airways, lowered specific IgE, induction of IgG2a antibodies in serum, immune deviation towards Th1 cytokine milieu, suppression of Th2 cytokines in BALF and splenocyte culture supernatant and resolution of lung inflammation. A significant increase in CD4+Foxp3+ cells in spleen indicate towards induction of T regulatory cell mediated peripheral tolerance characterized by shift in cytokine milieu from Th2 to T regulatory cytokines. PIT modulates regulation of immune responses at both local and systemic levels, contributes towards holistic improvement in allergic features in mice and thus demonstrate potential for safe, specific and efficacious treatment for cockroach allergy.Entities:
Keywords: Airway inflammation; Immune deviation; Immunotherapy; T cell; Th2 response; tolerance
Mesh:
Substances:
Year: 2019 PMID: 30795860 DOI: 10.1016/j.imbio.2019.01.003
Source DB: PubMed Journal: Immunobiology ISSN: 0171-2985 Impact factor: 3.144